Viewing Study NCT06081959


Ignite Creation Date: 2025-12-24 @ 2:44 PM
Ignite Modification Date: 2026-01-07 @ 11:40 AM
Study NCT ID: NCT06081959
Status: RECRUITING
Last Update Posted: 2025-12-05
First Post: 2023-10-07
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of SKB264 for Locally Advanced, Recurrent or Metastatic HR+/HER2- Breast Cancer
Sponsor: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module